Invention Grant
US07655411B2 Thrombospondin fragments and binding agents in the detection, diagnosis and evaluation of cancer
有权
血小板反应蛋白片段和结合剂在癌症的检测，诊断和评价中的应用
- Patent Title: Thrombospondin fragments and binding agents in the detection, diagnosis and evaluation of cancer
- Patent Title (中): 血小板反应蛋白片段和结合剂在癌症的检测，诊断和评价中的应用
-
Application No.: US10419462Application Date: 2003-04-21
-
Publication No.: US07655411B2Publication Date: 2010-02-02
- Inventor: Kevin J. Williams
- Applicant: Kevin J. Williams
- Applicant Address: US PA Philadelphia
- Assignee: W2 Holdings, Inc.
- Current Assignee: W2 Holdings, Inc.
- Current Assignee Address: US PA Philadelphia
- Agency: Caesar, Rivise, Bernstein, Cohen & Pokotilow, Ltd.
- Main IPC: G01N33/53
- IPC: G01N33/53 ; C12Q1/00 ; G01N33/48 ; G01N33/00 ; G01N1/00 ; G01N1/18
Abstract:
The invention relates to thrombospondin fragments found in plasma, their use or use of portions thereof in diagnostic methods, as method calibrators, method indicators, and as immunogens, and as analytes for methods with substantial clinical utility; and their detection in plasma or other bodily fluids for purpose of diagnostic methods, especially for cancer.
Public/Granted literature
Information query
IPC分类:
